Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Clopidogrel/repaglinide

Hypoglycaemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yue C, et al. Pharmacological monitoring of hypoglycemia caused by interaction between clopidogrel and repaglinide. [Chinese]. Adverse drug reactions journal 24: 664-666, No. 12, 28 Dec 2022. Available from: URL: http://www.cmaph.org/qkfc/index_2.htm [Chinese; summarised from a translation] Yue C, et al. Pharmacological monitoring of hypoglycemia caused by interaction between clopidogrel and repaglinide. [Chinese]. Adverse drug reactions journal 24: 664-666, No. 12, 28 Dec 2022. Available from: URL: http://​www.​cmaph.​org/​qkfc/​index_​2.​htm [Chinese; summarised from a translation]
Metadaten
Titel
Clopidogrel/repaglinide
Hypoglycaemia: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41390-4

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drug

Case report

Immune-globulin